The Senate passed H.R. 8454 (Medical #Marijuana and Cannabidiol #Research Expansion Act) by voice vote.
The #bill “would eliminate the red tape that hinders cannabis research, opening the door for new innovative treatments derived from cannabis,” Schumer said ahead of the vote. “If you’re one of the millions of Americans who deals with conditions like Parkinson’s or epilepsy or post-traumatic stress, or any number of other conditions, cannabis might hold promising new options for managing these diseases.”
“We need to do the research first,” he said. “And the federal government, sadly, has been woefully behind the times on this front. This bill will help fix that.
What’s in the Medical Marijuana and Cannabidiol Research Expansion Act?
It would streamline the application process for researchers who want to study the plant and to encourage the Food and Drug Administration (FDA) to develop cannabis-derived medicines.
It would also clarify that physicians are allowed to discuss the risks and benefits of marijuana with patients and require the U.S. Department of Health and Human Services (HHS) to submit a report on those potential health benefits, as well one on barriers to cannabis research and how to overcome those obstacles.
une into Cannabis Legalization News with host Tom Howard and Miggy420 as your dedicated source for all matters in the legal cannabis industry.
🌱 We can help with your cannabis business. Here is our Linktree.
🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr)
💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj)